Table 5 Spearman rank correlation analysis between the blood serum dopamine level and scores on extrapyramidal symptom scales in patients with schizophrenic disorder during the administration of antipsychotics
Indicator of peripheral biogenic amine | Blood serum dopamine level | Blood serum dopamine level | ||||||
|---|---|---|---|---|---|---|---|---|
Group of patients | Treated with haloperidol | Treated with olanzapine | ||||||
Administration of antipsychotic | Before treatment | Day 14 | Day 28 | Before treatment | Day 14 | Day 28 | ||
Scores on the extrapyramidal symptom scales: | −0.149 | −0.315 | ||||||
Administration of antipsychotic | Before treatment | SAS | ||||||
ESRS | −0.500 | −0.316 | ||||||
Day 14 | SAS | 0.292 | −0.465* | |||||
ESRS | 0.175 | −0.475* | ||||||
Day 28 | SAS | 0.037 | −0.609** | |||||
ESRS | 0.076 | −0.609** | ||||||